US Patent 8846603 NPP1 fusion proteins

Patent 8846603 was granted and assigned to Synageva BioPharma on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Synageva BioPharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8846603

Patent Inventor Names

Alex J. Harvey0

Anthony Quinn0

Zhinan Xia0

Date of Patent

September 30, 2014

Patent Application Number

13583973

Date Filed

March 11, 2011

Patent Citations Received

‌

US Patent 12134790 Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)

‌

US Patent 12076376 Methods for treating lysosomal acid lipase deficiency in patients

‌

US Patent 12128087 Compositions for treating pathological calcification conditions, and methods using same

Patent Primary Examiner

‌

Karlheinz R. Skowronek

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846603 NPP1 fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API